Lv4
540 积分 2022-08-01 加入
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
4小时前
待确认
Adoptive immunotherapy with cells from tumor-draining lymph nodes activated and expanded in vitro
2个月前
已完结
CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes
2个月前
已完结
Dendritic cell migration in health and disease
2个月前
已完结
IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model
5个月前
已完结
Identification of IL-4 As a Key Regulator of CAR T-Cell Exhaustion Using Functional Genomics and Correlates of the Zuma-1 Clinical Trial
5个月前
已完结
Identification of IL-4 As a Key Regulator of CAR T-Cell Exhaustion Using Functional Genomics and Correlates of the Zuma-1 Clinical Trial
5个月前
已关闭
Cytokines and Immune Response in the Tumor Microenvironment
5个月前
已完结
Errors in Data and Language
6个月前
已完结
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
7个月前
已完结
皖公网安备34019202002308
